LUC00007I2 - - Google Patents

Info

Publication number: LUC00007I2
Authority: LU; Luxembourg

Application number

LU00007C

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-03-15

Filing date

2017-03-01

Publication date

2017-05-02

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34962827&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LUC00007(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2017-03-01 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2017-03-03 Publication of LUC00007I1 publication Critical patent/LUC00007I1/fr

2017-05-02 Publication of LUC00007I2 publication Critical patent/LUC00007I2/fr

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/417—Imidazole-alkylamines, e.g. histamine, phentolamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
- C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom

LU00007C 2004-03-15 2017-03-01 LUC00007I2 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US55334204P	2004-03-15	2004-03-15
PCT/US2005/008339 WO2005090315A1 (fr)	2004-03-15	2005-03-14	Nouveaux composes en tant que modulateurs de recepteurs d'opioides

Publications (2)

Publication Number	Publication Date
LUC00007I1 LUC00007I1 (fr)	2017-03-03
LUC00007I2 true LUC00007I2 (fr)	2017-05-02

Family

ID=34962827

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LU00007C LUC00007I2 (fr)	2004-03-15	2017-03-01

Country Status (36)

Country	Link
US (8)	US7741356B2 (fr)
EP (5)	EP1725537B1 (fr)
JP (1)	JP4778954B2 (fr)
KR (1)	KR101166342B1 (fr)
CN (2)	CN1950342B (fr)
AR (2)	AR048269A1 (fr)
AT (1)	ATE516274T1 (fr)
AU (1)	AU2005224091B2 (fr)
BR (1)	BRPI0508820B8 (fr)
CA (1)	CA2560047C (fr)
CR (1)	CR8655A (fr)
CY (3)	CY1111927T1 (fr)
DK (5)	DK2573068T3 (fr)
EC (1)	ECSP066856A (fr)
ES (5)	ES2596434T3 (fr)
HK (4)	HK1099016A1 (fr)
HR (4)	HRP20110694T1 (fr)
HU (2)	HUE029852T2 (fr)
IL (3)	IL178040A (fr)
LT (2)	LT2653465T (fr)
LU (1)	LUC00007I2 (fr)
ME (3)	ME01601B (fr)
MX (1)	MXPA06010642A (fr)
MY (1)	MY146972A (fr)
NL (1)	NL300865I2 (fr)
NO (3)	NO338203B1 (fr)
NZ (1)	NZ549842A (fr)
PH (1)	PH12012501640A1 (fr)
PL (4)	PL2653465T3 (fr)
PT (4)	PT2298744E (fr)
RS (4)	RS55122B1 (fr)
SI (4)	SI2298744T1 (fr)
TW (1)	TWI361069B (fr)
UA (1)	UA86053C2 (fr)
WO (1)	WO2005090315A1 (fr)
ZA (1)	ZA200608587B (fr)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI239847B (en)	1997-12-02	2005-09-21	Elan Pharm Inc	N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
US20080050367A1 (en)	1998-04-07	2008-02-28	Guriq Basi	Humanized antibodies that recognize beta amyloid peptide
SI2298744T1 (sl)	2004-03-15	2013-10-30	Janssen Pharmaceutica N.V.	Modulatorji opioidnega receptorja
WO2005113486A1 (fr)	2004-05-14	2005-12-01	Janssen Pharmaceutica N.V.	Composes carboxamido opioides
WO2006066089A1 (fr)	2004-12-15	2006-06-22	Neuralab Limited	Anticorps du peptide beta-amyloide humanises utilises dans l'amelioration de la cognition
JP5384933B2 (ja) *	2005-03-14	2014-01-08	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	オピオイド調節物質の製造方法
JP5225098B2 (ja) *	2005-12-14	2013-07-03	ブリストル−マイヤーズスクイブカンパニー	第ＸＩａ因子インヒビターとしてのアリールプロピオンアミド、アリールアクリルアミド、アリールプロピンアミド、またはアリールメチルウレアアナログ
AU2006332945C1 (en) *	2005-12-23	2013-02-28	Wyeth	Modified lysine-mimetic compounds
MX2008012991A (es)	2006-04-07	2008-10-17	Procter & Gamble	Anticuerpos que ligan proteina tirosina fosfatasa humana beta (hptpbeta) y los usos de estos.
US8784810B2 (en)	2006-04-18	2014-07-22	Janssen Alzheimer Immunotherapy	Treatment of amyloidogenic diseases
US7622593B2 (en)	2006-06-27	2009-11-24	The Procter & Gamble Company	Human protein tyrosine phosphatase inhibitors and methods of use
EP2074087A2 (fr) *	2006-12-21	2009-07-01	Wyeth	Synthese de composes de pyrrolidine
AU2008275270C1 (en)	2007-07-09	2014-04-17	Allergan Holdings Unlimited Company	Novel crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid
PL2182983T3 (pl)	2007-07-27	2014-10-31	Janssen Alzheimer Immunotherap	Leczenie chorób amyloidowych z wykorzystaniem humanizowanych przeciwciał specyficznych względem Abeta
JO3076B1 (ar)	2007-10-17	2017-03-15	Janssen Alzheimer Immunotherap	نظم العلاج المناعي المعتمد على حالة apoe
TWI468375B (zh) *	2008-10-27	2015-01-11	Janssen Pharmaceutica Nv	製備經保護之ｌ－丙胺酸衍生物之方法
US9067981B1 (en)	2008-10-30	2015-06-30	Janssen Sciences Ireland Uc	Hybrid amyloid-beta antibodies
JP5198220B2 (ja) *	2008-11-13	2013-05-15	東ソ−・エフテック株式会社	アミノ酸誘導体の製造方法
CA2748765C (fr)	2009-07-06	2014-07-22	Akebia Therapeutics Inc.	Composes, compositions et methodes de prevention de la metastase cancereuse
JP6254075B2 (ja)	2011-05-16	2017-12-27	バイオノミックスリミテッド	カリウムチャネル遮断剤としてのアミン誘導体
EP2524912A1 (fr)	2011-05-16	2012-11-21	Bionomics Limited	Amine derivatives
MX363351B (es)	2011-10-13	2019-03-20	Aerpio Therapeutics Inc	Un agente de unión a hptp?-ecd para usarse en el tratamiento de síndrome de fuga vascular.
US9023883B2 (en)	2013-03-14	2015-05-05	Epizyme, Inc.	PRMT1 inhibitors and uses thereof
WO2014153172A1 (fr) *	2013-03-14	2014-09-25	Epizyme, Inc.	Dérivés de pyrazole en tant qu'inhibiteurs de prmt1 et leurs utilisations
EP2970132B1 (fr)	2013-03-14	2020-09-23	Epizyme, Inc.	Inhibiteurs d'arginine méthyltransférase et leurs utilisations
US9675587B2 (en)	2013-03-14	2017-06-13	Allergan Holdings Unlimited Company	Opioid receptor modulator dosage formulations
US9120757B2 (en)	2013-03-14	2015-09-01	Epizyme, Inc.	Arginine methyltransferase inhibitors and uses thereof
US20150050277A1 (en)	2013-03-15	2015-02-19	Aerpio Therapeutics Inc.	Compositions and methods for treating ocular diseases
EP3116503A4 (fr)	2014-03-14	2017-08-23	Aerpio Therapeutics, Inc.	Inhibiteurs de hptp-bêta
IS2977B (is)	2015-02-23	2017-07-15	Actavis Group Ptc Ehf.	Aðferð til framleiðslu á milliefnum sem eru nytsamleg við nýsmíði á elúxadólíni
US10702498B2 (en)	2015-07-09	2020-07-07	The Regents Of The University Of California	MU opioid receptor modulators
US10314819B2 (en)	2015-07-23	2019-06-11	Teva Pharmaceuticals International Gmbh	Solid state forms of Eluxadoline
JPWO2017043626A1 (ja) *	2015-09-11	2018-06-21	株式会社カネカ	光学活性４−カルバモイル−２，６−ジメチルフェニルアラニン誘導体の製造法
JP6959924B2 (ja)	2015-09-23	2021-11-05	エアーピオファーマシューティカルズ，インコーポレイテッド	Ｔｉｅ−２の活性化物質を用いる眼内圧を処置する方法
CN105250232B (zh) *	2015-09-29	2018-08-14	江苏汇智知识产权服务有限公司	一种伊卢多啉肠溶片及其制备方法
WO2017114446A1 (fr) *	2015-12-31	2017-07-06	苏州晶云药物科技有限公司	Nouvelle forme cristalline d'éluxadoline, et son procédé de préparation
CN107129444B (zh) *	2016-02-29	2018-08-31	尚科生物医药（上海）有限公司	(s)-2-叔丁氧羰基氨基-3-(4-氨甲酰基-2,6-二甲基苯基)丙酸制备方法
EP3272741A1 (fr)	2016-07-21	2018-01-24	Euticals S.P.A.	Nouvelles formes cristallines de solvate stable d'eluxadoline
CN105777584B (zh) *	2016-03-28	2018-01-02	成都伊诺达博医药科技有限公司	丙氨酸衍生物的制备方法
CN105693554B (zh) *	2016-04-06	2017-08-08	成都伊诺达博医药科技有限公司	丙氨酸衍生物的制备方法
WO2017191650A1 (fr) *	2016-05-03	2017-11-09	Msn Laboratories Private Limited	Procédé de préparation de l'acide 5-[[[(2s)-2-amino-3-[4-(aminocarbonyl)-2,6-diméthylphényl]-1-oxopropyl][(1s)-1-(4-phényl-1h-imidazol-2-yl)éthyl]amino]méthyl-2-méthoxybenzoïque et ses polymorphes
EP3463333A4 (fr) *	2016-05-30	2019-11-20	Sun Pharmaceutical Industries Limited	Procédé de préparation de l'éluxadoline .
WO2017221213A1 (fr) *	2016-06-23	2017-12-28	Sun Pharmaceutical Industries Limited	Méthodes de préparation d'oxazoldinone.
WO2018020450A2 (fr)	2016-07-28	2018-02-01	Lupin Limited	Procédé de préparation d'eluxadoline
CZ2016548A3 (cs)	2016-09-07	2018-03-14	Zentiva, K.S.	Pevné formy eluxadolinu
WO2018047131A1 (fr) *	2016-09-09	2018-03-15	Sun Pharmaceutical Industries Limited	Éluxadoline amorphe
EP3515434A4 (fr)	2016-09-20	2020-02-26	Sun Pharmaceutical Industries Limited	Procédés pour la préparation d'éluxadoline
WO2018138272A1 (fr)	2017-01-27	2018-08-02	Quimica Sintetica, S. A.	Forme cristalline d'éluxadoline et son procédé de préparation
EP3573958A1 (fr)	2017-01-27	2019-12-04	Quimica Sintetica, S.A.	Formes cristallines d'éluxadoline et leurs procédés de préparation
DK3618847T3 (da)	2017-05-05	2021-05-25	Boston Medical Ct Corp	GAP-junction-modulatorer af intercellulær kommunikation og deres anvendelse til behandling af diabetisk øjensygdom
WO2019008604A1 (fr)	2017-07-07	2019-01-10	Cipla Limited	Nouvelles formes d'agoniste du récepteur mu-opioïde
WO2019144805A1 (fr) *	2018-01-25	2019-08-01	四川科伦博泰生物医药股份有限公司	Composé phényléthylamine substitué et son procédé de préparation et son utilisation
WO2019197274A1 (fr)	2018-04-09	2019-10-17	Quimica Sintetica, S. A.	Procédé de préparation de modulateurs d'opioïdes
US20210251964A1 (en)	2018-08-20	2021-08-19	Allergan Holdings Unlimited Company	Polymorphs of 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid
WO2020068653A1 (fr)	2018-09-24	2020-04-02	Aerpio Pharmaceuticals, Inc.	ANTICORPS MULTISPÉCIFIQUES CIBLANT HPTP- β (VE-PTP) ET VEGF
PL3659433T3 (pl) *	2018-11-30	2021-11-08	Phytobiotics Futterzusatzstoffe Gmbh	System analizowania obrazów wydzielin zwierzęcych
CN111377832A (zh) *	2018-12-27	2020-07-07	江苏联昇化学有限公司	一种伊卢多啉中间体制备的新方法
US11253502B2 (en)	2019-04-29	2022-02-22	EyePoint Pharmaceuticals, Inc.	Tie-2 activators targeting the Schlemm's canal
US20230118152A1 (en)	2020-03-30	2023-04-20	Allergan Holdings Unlimited Company	Forms of 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid
IL300110A (en) *	2020-07-28	2023-03-01	Jazz Pharmaceuticals Ireland Ltd	Chiral synthesis of RAF inhibitors in compressed cyclics
US11850319B2 (en)	2020-09-29	2023-12-26	Abl Ip Holding Llc	Techniques for directing ultraviolet energy towards a moving surface
US20220096676A1 (en)	2020-09-29	2022-03-31	Abl Ip Holding Llc	Techniques for Directing Ultraviolet Energy Towards a Moving Surface
CN114163348A (zh) *	2020-11-27	2022-03-11	成都泰蓉生物科技有限公司	一种氨酰基取代的l-苯丙氨酸的合成方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DD142804A3 (de) *	1977-11-07	1980-07-16	Wagner Guenter	Verfahren zur herstellung von na-alkyl-bzw.na-aryl-sulfonylierten omega-amidinophenyl-alpha-aminoalkylcarbonsaeureamiden
US4879398A (en) *	1987-12-31	1989-11-07	Monsanto Company	Process for producing 2,6-disubstituted tyrosine
SE9402880D0 (sv)	1994-08-30	1994-08-30	Astra Ab	New peptide derivatives
ATE272069T1 (de)	1995-01-27	2004-08-15	Novo Nordisk As	Verbindungen mit wachstumshormon-freisetzenden eigenschaften
US5565568A (en)	1995-04-06	1996-10-15	Eli Lilly And Company	2-acylaminopropanamides as tachykinin receptor antagonists
KR100414321B1 (ko)	1995-04-13	2004-02-18	아벤티스 파마슈티칼스 인크.	타치키닌수용체길항활성을갖는신규한치환된피페라진유도체
CA2203428A1 (fr)	1995-08-21	1997-02-27	Philip Arthur Hipskind	2-acylaminopropanamides en tant que secretagogues d'hormones de croissance
AU7710596A (en)	1995-11-29	1997-06-19	Nihon Nohyaku Co., Ltd.	Phenylalanine derivatives, optically active substances, salts or coordination compounds thereof, and their use as fungicides
US5792760A (en)	1997-04-23	1998-08-11	Eli Lilly And Company	Bisindoles as tachykinin receptor antagonists
IT1304898B1 (it)	1998-09-08	2001-04-05	Menarini Ricerche Spa	Prodotti con caratteristiche basiche aventi attivita' antagonista sulrecettore nk-1 e loro impiego in preparazioni farmaceutiche
PT1055665E (pt) *	1999-05-28	2004-03-31	Pfizer Prod Inc	Derivados da 3-(3-hidroxifenil)-3-amino-propionamida
FR2796643B1 (fr)	1999-07-22	2005-04-29	Sod Conseils Rech Applic	Derives de 2-arylimino-2, 3-dihydrothiazoles, leurs procedes de preparation et leur utilisation therapeutique
GB0021419D0 (en)	2000-08-31	2000-10-18	Oxford Glycosciences Uk Ltd	Compounds
US20020072017A1 (en) *	2000-10-19	2002-06-13	Hudnall Phillip Montgomery	Stabilized p-phenylenediamine-type photographic color developers in free base form
US7125891B2 (en)	2000-10-30	2006-10-24	Janssen Pharmaceutica N.V.	Tripeptidyl peptidase inhibitors
PL367967A1 (en) *	2001-10-15	2005-03-07	Janssen Pharmaceutica N.V.	Novel substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta opioid agonists
US7041681B2 (en)	2002-04-29	2006-05-09	Janssen Pharmaceutica N.V.	Compounds as opioid receptor modulators
SI2298744T1 (sl)	2004-03-15	2013-10-30	Janssen Pharmaceutica N.V.	Modulatorji opioidnega receptorja
AU2005243240B2 (en) *	2004-05-03	2012-03-15	Janssen Pharmaceutica N.V.	Novel indole derivatives as selective androgen receptor modulators (SARMS)
JP5384933B2 (ja) *	2005-03-14	2014-01-08	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	オピオイド調節物質の製造方法

2005
- 2005-03-14 SI SI200531771T patent/SI2298744T1/sl unknown
- 2005-03-14 DK DK12194058.9T patent/DK2573068T3/en active
- 2005-03-14 RS RS20160843A patent/RS55122B1/sr unknown
- 2005-03-14 PL PL13173454T patent/PL2653465T3/pl unknown
- 2005-03-14 CA CA2560047A patent/CA2560047C/fr active Active
- 2005-03-14 EP EP05728171A patent/EP1725537B1/fr active Active
- 2005-03-14 PL PL12194058T patent/PL2573068T3/pl unknown
- 2005-03-14 BR BRPI0508820A patent/BRPI0508820B8/pt not_active IP Right Cessation
- 2005-03-14 EP EP16178050.7A patent/EP3112352B1/fr active Active
- 2005-03-14 ME MEP-2013-97A patent/ME01601B/me unknown
- 2005-03-14 KR KR1020067021231A patent/KR101166342B1/ko active IP Right Grant
- 2005-03-14 EP EP10182349.0A patent/EP2298744B1/fr active Active
- 2005-03-14 ME MEP-2015-36A patent/ME02221B/me unknown
- 2005-03-14 EP EP13173454.3A patent/EP2653465B1/fr active Active
- 2005-03-14 PL PL05728171T patent/PL1725537T3/pl unknown
- 2005-03-14 MX MXPA06010642A patent/MXPA06010642A/es active IP Right Grant
- 2005-03-14 ES ES13173454.3T patent/ES2596434T3/es active Active
- 2005-03-14 CN CN200580014571XA patent/CN1950342B/zh not_active Expired - Fee Related
- 2005-03-14 PT PT101823490T patent/PT2298744E/pt unknown
- 2005-03-14 DK DK16178050.7T patent/DK3112352T3/en active
- 2005-03-14 RS RS20130371A patent/RS52933B/en unknown
- 2005-03-14 EP EP12194058.9A patent/EP2573068B9/fr active Active
- 2005-03-14 HU HUE13173454A patent/HUE029852T2/en unknown
- 2005-03-14 UA UAA200609824A patent/UA86053C2/ru unknown
- 2005-03-14 RS RS20110446A patent/RS51995B/en unknown
- 2005-03-14 SI SI200531934T patent/SI2573068T1/sl unknown
- 2005-03-14 SI SI200531383T patent/SI1725537T1/sl unknown
- 2005-03-14 US US11/079,647 patent/US7741356B2/en active Active
- 2005-03-14 ES ES12194058.9T patent/ES2533176T3/es active Active
- 2005-03-14 WO PCT/US2005/008339 patent/WO2005090315A1/fr active Application Filing
- 2005-03-14 AU AU2005224091A patent/AU2005224091B2/en not_active Ceased
- 2005-03-14 DK DK05728171.9T patent/DK1725537T3/da active
- 2005-03-14 LT LTEP13173454.3T patent/LT2653465T/lt unknown
- 2005-03-14 NZ NZ549842A patent/NZ549842A/en not_active IP Right Cessation
- 2005-03-14 DK DK10182349.0T patent/DK2298744T3/da active
- 2005-03-14 PL PL10182349T patent/PL2298744T3/pl unknown
- 2005-03-14 JP JP2007503986A patent/JP4778954B2/ja not_active Expired - Fee Related
- 2005-03-14 PT PT121940589T patent/PT2573068E/pt unknown
- 2005-03-14 PT PT131734543T patent/PT2653465T/pt unknown
- 2005-03-14 SI SI200532091A patent/SI2653465T1/sl unknown
- 2005-03-14 PT PT05728171T patent/PT1725537E/pt unknown
- 2005-03-14 TW TW094107612A patent/TWI361069B/zh not_active IP Right Cessation
- 2005-03-14 ME MEP-2016-232A patent/ME02540B/fr unknown
- 2005-03-14 ES ES16178050T patent/ES2705077T3/es active Active
- 2005-03-14 AT AT05728171T patent/ATE516274T1/de active
- 2005-03-14 ES ES10182349T patent/ES2428008T3/es active Active
- 2005-03-14 RS RS20150204A patent/RS54199B1/en unknown
- 2005-03-14 DK DK13173454.3T patent/DK2653465T3/da active
- 2005-03-14 CN CN201210277845.6A patent/CN102786476B/zh not_active Expired - Fee Related
- 2005-03-14 ES ES05728171T patent/ES2367576T3/es active Active
- 2005-03-14 MY MYPI20051060A patent/MY146972A/en unknown
- 2005-03-15 AR ARP050101007A patent/AR048269A1/es active IP Right Grant
2006
- 2006-09-12 IL IL178040A patent/IL178040A/en active IP Right Grant
- 2006-09-15 EC EC2006006856A patent/ECSP066856A/es unknown
- 2006-09-25 CR CR8655A patent/CR8655A/es unknown
- 2006-10-13 ZA ZA2006/08587A patent/ZA200608587B/en unknown
- 2006-10-13 NO NO20064660A patent/NO338203B1/no not_active IP Right Cessation
2007
- 2007-05-28 HK HK07105593.3A patent/HK1099016A1/xx not_active IP Right Cessation
- 2007-10-17 HK HK07111210.4A patent/HK1105967A1/xx not_active IP Right Cessation
- 2007-10-24 US US11/877,747 patent/US7786158B2/en active Active
2010
- 2010-07-19 US US12/838,825 patent/US8344011B2/en active Active
2011
- 2011-09-19 HK HK11109830.2A patent/HK1155726A1/xx not_active IP Right Cessation
- 2011-09-28 HR HR20110694T patent/HRP20110694T1/hr unknown
- 2011-10-10 CY CY20111100967T patent/CY1111927T1/el unknown
2012
- 2012-08-14 PH PH12012501640A patent/PH12012501640A1/en unknown
- 2012-11-30 US US13/690,041 patent/US8609709B2/en active Active
2013
- 2013-02-26 IL IL224908A patent/IL224908A/en active IP Right Grant
- 2013-08-22 HR HRP20130800TT patent/HRP20130800T1/hr unknown
- 2013-09-27 HK HK13111031.3A patent/HK1184432A1/xx not_active IP Right Cessation
- 2013-10-03 US US14/045,008 patent/US8772325B2/en active Active
- 2013-11-14 IL IL229444A patent/IL229444A/en active IP Right Grant
2014
- 2014-04-11 AR ARP140101566A patent/AR095848A2/es unknown
- 2014-05-20 US US14/282,828 patent/US9205076B2/en active Active
2015
- 2015-03-18 HR HRP20150305TT patent/HRP20150305T1/hr unknown
- 2015-10-12 US US14/880,597 patent/US9700542B2/en active Active
2016
- 2016-05-30 NO NO20160916A patent/NO20160916A1/no not_active Application Discontinuation
- 2016-10-12 CY CY20161101019T patent/CY1118096T1/el unknown
- 2016-10-12 HR HRP20161331TT patent/HRP20161331T1/hr unknown
2017
- 2017-02-23 NO NO2017007C patent/NO2017007I1/no unknown
- 2017-03-01 LU LU00007C patent/LUC00007I2/fr unknown
- 2017-03-01 LT LTPA2017005C patent/LTC1725537I2/lt unknown
- 2017-03-02 HU HUS1700010C patent/HUS1700010I1/hu unknown
- 2017-03-08 CY CY2017008C patent/CY2017008I1/el unknown
- 2017-03-10 NL NL300865C patent/NL300865I2/nl unknown
- 2017-06-07 US US15/616,358 patent/US10213415B2/en active Active

Also Published As

Publication number	Publication date
NL300865I1 (nl)	2017-03-14
NL300865I2 (nl)	2020-08-17
IL178040A (en)	2013-12-31
TWI361069B (en)	2012-04-01
US20080096888A1 (en)	2008-04-24
TW200539876A (en)	2005-12-16
CA2560047A1 (fr)	2005-09-29
US20180325870A1 (en)	2018-11-15
EP1725537A1 (fr)	2006-11-29
BRPI0508820B1 (pt)	2018-04-10
PT2298744E (pt)	2013-09-12
CR8655A (es)	2008-09-09
DK3112352T3 (en)	2019-01-28
US20160030393A1 (en)	2016-02-04
PL2298744T3 (pl)	2013-11-29
ES2533176T3 (es)	2015-04-08
US8609709B2 (en)	2013-12-17
KR20060131983A (ko)	2006-12-20
CN102786476A (zh)	2012-11-21
DK2573068T3 (en)	2015-02-16
ZA200608587B (en)	2008-06-25
CN1950342B (zh)	2012-09-26
LTPA2017005I1 (lt)	2017-03-27
US9700542B2 (en)	2017-07-11
MXPA06010642A (es)	2007-03-26
CN102786476B (zh)	2017-01-18
BRPI0508820A (pt)	2007-08-07
EP2298744A3 (fr)	2011-08-10
HK1105967A1 (en)	2008-02-29
EP2298744A2 (fr)	2011-03-23
PT2653465T (pt)	2016-09-22
ES2596434T3 (es)	2017-01-09
US7741356B2 (en)	2010-06-22
JP4778954B2 (ja)	2011-09-21
CN1950342A (zh)	2007-04-18
DK2298744T3 (da)	2013-09-02
NO338203B1 (no)	2016-08-08
CY1118096T1 (el)	2017-06-28
LTC1725537I2 (lt)	2018-02-26
US20140256779A1 (en)	2014-09-11
US8772325B2 (en)	2014-07-08
LUC00007I1 (fr)	2017-03-03
NO20160916A1 (no)	2006-12-14
HRP20150305T1 (hr)	2015-04-24
US10213415B2 (en)	2019-02-26
US20050203143A1 (en)	2005-09-15
PH12012501640B1 (en)	2015-10-05
HK1184432A1 (en)	2014-01-24
CY2017008I2 (el)	2017-11-14
LT2653465T (lt)	2016-09-12
HK1099016A1 (en)	2007-08-03
ME02221B (me)	2016-02-20
CA2560047C (fr)	2013-12-24
JP2007529527A (ja)	2007-10-25
SI1725537T1 (sl)	2011-11-30
US9205076B2 (en)	2015-12-08
HRP20161331T1 (hr)	2016-12-30
RS52933B (en)	2014-02-28
PL1725537T3 (pl)	2011-12-30
IL178040A0 (en)	2006-12-31
ME02540B (fr)	2017-02-20
EP2298744B1 (fr)	2013-06-26
EP2573068A1 (fr)	2013-03-27
WO2005090315A1 (fr)	2005-09-29
PL2653465T3 (pl)	2017-01-31
AU2005224091A1 (en)	2005-09-29
BRPI0508820B8 (pt)	2022-11-29
AR095848A2 (es)	2015-11-18
EP1725537B1 (fr)	2011-07-13
NO2017007I2 (no)	2017-02-23
SI2653465T1 (sl)	2016-10-28
US20100324051A1 (en)	2010-12-23
ATE516274T1 (de)	2011-07-15
RS54199B1 (en)	2015-12-31
CY2017008I1 (el)	2017-11-14
IL224908A (en)	2015-07-30
NZ549842A (en)	2010-10-29
ES2428008T3 (es)	2013-11-05
MY146972A (en)	2012-10-15
US20140039024A1 (en)	2014-02-06
PT2573068E (pt)	2015-04-27
DK2653465T3 (da)	2016-08-22
ES2367576T3 (es)	2011-11-04
PH12012501640A1 (en)	2015-10-05
DK1725537T3 (da)	2011-10-31
PL2573068T3 (pl)	2015-06-30
EP2653465A1 (fr)	2013-10-23
NO20064660L (no)	2006-12-14
HRP20130800T1 (en)	2013-09-30
KR101166342B1 (ko)	2012-07-18
PT1725537E (pt)	2011-09-08
SI2573068T1 (sl)	2015-03-31
SI2298744T1 (sl)	2013-10-30
RS51995B (en)	2012-04-30
UA86053C2 (ru)	2009-03-25
US7786158B2 (en)	2010-08-31
EP3112352A1 (fr)	2017-01-04
AR048269A1 (es)	2006-04-12
NO2017007I1 (no)	2017-02-23
IL229444A0 (en)	2013-12-31
HUS1700010I1 (hu)	2017-03-28
AU2005224091B2 (en)	2012-02-02
EP2653465B1 (fr)	2016-07-13
HUE029852T2 (en)	2017-04-28
US8344011B2 (en)	2013-01-01
EP2573068B1 (fr)	2014-12-31
HK1155726A1 (en)	2012-05-25
CY1111927T1 (el)	2015-11-04
ECSP066856A (es)	2006-11-24
EP3112352B1 (fr)	2018-11-21
EP2573068B9 (fr)	2015-08-26
ME01601B (me)	2014-09-20
US20130090478A1 (en)	2013-04-11
ES2705077T3 (es)	2019-03-21
IL229444A (en)	2017-03-30
HRP20110694T1 (hr)	2011-12-31
RS55122B1 (sr)	2016-12-30

Publication	Publication Date	Title
BE2015C038I2 (fr)	2019-10-23
BRPI0518216C1 (fr)	2017-03-21
BRPI0515516B8 (fr)	2021-05-25
BR122015024347A2 (fr)	2006-12-26
BRPI0508002A (fr)	2007-07-03
JP2005292952A5 (fr)	2007-04-19
BR122018073034B8 (fr)	2022-10-11
BRPI0508029A (fr)	2007-07-03
BRPI0419105B8 (fr)	2021-05-25
JP2005212877A5 (fr)	2007-01-11
JP2004347603A5 (fr)	2007-07-05
BRPI0508026A (fr)	2007-07-03
JP2005189233A5 (fr)	2008-01-10
JP2005039198A5 (fr)	2005-09-15
JP2005333804A5 (fr)	2007-07-12
JP2005268125A5 (fr)	2007-04-19
BRPI0508033A (fr)	2007-07-03
AT501137B8 (fr)	2007-02-15
JP2004344173A5 (fr)	2005-07-28
JP2005234300A5 (fr)	2006-09-14
JP2005343038A5 (fr)	2007-07-19
AT500847B8 (fr)	2007-02-15
CN300731631S (zh)	2008-01-16	衣架
CN300737968S (zh)	2008-01-30	窄锯条锯机
CN300729373S (zh)	2008-01-09	包装盒（曲面的蛤壳式）